| |
| |
|
| Insider
Information: |
Chin Simon |
| Relationship: |
Chief Executive Office... |
| City: |
Santa Clara |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
15,006,142 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$600,246 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
15,006,142 |
|
|
| Total
Value |
$600,246 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Iris Biotechnologies Inc |
IRSB |
Chief Executive Office... |
2017-12-20 |
15,006,142 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
87 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IRSB |
Iris Biotechnologies Inc |
Chief Executive Officer |
• • • |
2016-11-29 |
4 |
S |
$0.09 |
$910 |
D/D |
(10,000) |
12,734,313 |
0 |
- |
|
| IRSB |
Iris Biotechnologies Inc |
Chief Executive Officer |
• • • |
2016-11-30 |
4 |
S |
$0.09 |
$1,185 |
D/D |
(12,500) |
12,721,813 |
0 |
- |
|
| IRSB |
Iris Biotechnologies Inc |
Chief Executive Officer |
• • • |
2016-12-01 |
4 |
S |
$0.09 |
$2,040 |
D/D |
(20,000) |
12,701,813 |
0 |
- |
|
| IRSB |
Iris Biotechnologies Inc |
Chief Executive Officer |
• • • |
2016-12-02 |
4 |
S |
$0.08 |
$1,723 |
D/D |
(21,250) |
12,680,563 |
0 |
- |
|
| IRSB |
Iris Biotechnologies Inc |
Chief Executive Officer |
• • • |
2016-12-23 |
4 |
A |
$0.13 |
$41,665 |
D/D |
320,500 |
13,001,063 |
0 |
- |
|
| IRSB |
Iris Biotechnologies Inc |
Chief Executive Officer |
• • • |
2017-03-09 |
4 |
A |
$0.18 |
$62,500 |
D/D |
339,674 |
13,340,737 |
0 |
- |
|
| IRSB |
Iris Biotechnologies Inc |
Chief Executive Officer |
• • • |
2017-06-02 |
4 |
A |
$0.21 |
$41,667 |
D/D |
198,413 |
13,539,150 |
0 |
- |
|
| IRSB |
Iris Biotechnologies Inc |
Chief Executive Officer |
• • • |
2017-08-09 |
4 |
A |
$0.10 |
$41,667 |
D/D |
416,670 |
13,955,820 |
0 |
- |
|
| IRSB |
Iris Biotechnologies Inc |
Chief Executive Officer |
• • • |
2017-09-15 |
4 |
A |
$0.10 |
$31,250 |
D/D |
312,500 |
14,268,320 |
0 |
- |
|
| IRSB |
Iris Biotechnologies Inc |
Chief Executive Officer |
• • • |
2017-11-17 |
4 |
A |
$0.12 |
$41,667 |
D/D |
347,222 |
14,615,542 |
0 |
- |
|
| IRSB |
Iris Biotechnologies Inc |
Chief Executive Officer |
• • • |
2017-12-20 |
4 |
A |
$0.08 |
$31,248 |
D/D |
390,600 |
15,006,142 |
0 |
- |
|
| IRSB |
Iris Biotechnologies Inc |
Chief Executive OfficerOfficer |
• • • |
2008-05-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,200,000 |
|
- |
|
87 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
